These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27695661)

  • 1. Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I.
    Bondy-Chorney E; Crawford Parks TE; Ravel-Chapuis A; Jasmin BJ; Côté J
    Rare Dis; 2016; 4(1):e1225644. PubMed ID: 27695661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier.
    Bondy-Chorney E; Crawford Parks TE; Ravel-Chapuis A; Klinck R; Rocheleau L; Pelchat M; Chabot B; Jasmin BJ; Côté J
    PLoS Genet; 2016 Jan; 12(1):e1005827. PubMed ID: 26824521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing.
    Ravel-Chapuis A; Bélanger G; Yadava RS; Mahadevan MS; DesGroseillers L; Côté J; Jasmin BJ
    J Cell Biol; 2012 Mar; 196(6):699-712. PubMed ID: 22431750
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bosè F; Renna LV; Fossati B; Arpa G; Labate V; Milani V; Botta A; Micaglio E; Meola G; Cardani R
    Front Neurol; 2019; 10():992. PubMed ID: 31611837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
    Savkur RS; Philips AV; Cooper TA
    Nat Genet; 2001 Sep; 29(1):40-7. PubMed ID: 11528389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients.
    Ravel-Chapuis A; Klein Gunnewiek A; Bélanger G; Crawford Parks TE; Côté J; Jasmin BJ
    Mol Biol Cell; 2016 Jun; 27(11):1728-39. PubMed ID: 27030674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.
    Leroy O; Wang J; Maurage CA; Parent M; Cooper T; Buée L; Sergeant N; Andreadis A; Caillet-Boudin ML
    Biochim Biophys Acta; 2006 Apr; 1762(4):460-7. PubMed ID: 16487687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
    Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroscopic and microscopic diversity of missplicing in the central nervous system of patients with myotonic dystrophy type 1.
    Furuta M; Kimura T; Nakamori M; Matsumura T; Fujimura H; Jinnai K; Takahashi MP; Mochizuki H; Yoshikawa H
    Neuroreport; 2018 Feb; 29(3):235-240. PubMed ID: 29381654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
    Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
    Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
    Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
    Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic protein dysregulation in myotonic dystrophy type 1: Disease neuropathogenesis beyond missplicing.
    Hernández-Hernández O; Sicot G; Dinca DM; Huguet A; Nicole A; Buée L; Munnich A; Sergeant N; Gourdon G; Gomes-Pereira M
    Rare Dis; 2013; 1():e25553. PubMed ID: 25003003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol enhances splicing of insulin receptor exon 11 in myotonic dystrophy type 1 fibroblasts.
    Takarada T; Nishida A; Takeuchi A; Lee T; Takeshima Y; Matsuo M
    Brain Dev; 2015 Aug; 37(7):661-8. PubMed ID: 25476247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
    Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
    Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis].
    Furling D
    Rinsho Shinkeigaku; 2012; 52(11):1018-22. PubMed ID: 23196502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
    Leroy O; Dhaenens CM; Schraen-Maschke S; Belarbi K; Delacourte A; Andreadis A; Sablonnière B; Buée L; Sergeant N; Caillet-Boudin ML
    J Neurosci Res; 2006 Sep; 84(4):852-9. PubMed ID: 16862542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.